Results 171 to 180 of about 11,467 (229)
Dual-biomarker strategy for prenatal prediction of ABO hemolytic disease: Maternal sVE-cadherin and anti-A/B IgG titer. [PDF]
Jiang DD, Li JW, Zhang XC.
europepmc +1 more source
Adverse perinatal outcomes indicative of RhD-mediated hemolytic disease of the fetus and newborn in Eastern Ethiopia: evidence of maternal health inequity in a multicenter cohort study. [PDF]
Desalew A +9 more
europepmc +1 more source
Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM). [PDF]
Tjoa ML +8 more
europepmc +1 more source
Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy
T Kanra, M Tunçer, A Pirnar
doaj
Some of the next articles are maybe not open access.
Related searches:
Related searches:
ABO Hemolytic Disease of the Newborn
American Journal of Clinical Pathology, 1979The charts of newborn infants with positive direct Coombs' test were studied. Only cases in which the mother's blood was group O and the infant's group A or group B were studied. There was no difference between group A and group B infants in the frequency and severity of the hemolytic process caused by maternal antibodies.
S Y, Chan-Shu, O, Blair
openaire +2 more sources
Neutropenia In Infants with Hemolytic Disease of the Newborn.
Blood, 2010Abstract Abstract 3794 Introduction: Hemolytic disease of the newborn (HDN) results from maternal IgG antibodies that cross the placenta into the fetal circulation during gestation and cause red blood cell (RBC) destruction.
Esther, Blanco, Donna L, Johnston
openaire +2 more sources

